Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Genomic Pathology and Cancer Biomarkers: Prostate Cancer

Volume 22, Issue 5-6, 2017, pp. 515-525
DOI: 10.1615/CritRevOncog.2017020539
Get accessGet access

ABSTRACT

Our understanding of genomic pathology and biomarkers for prostate cancer is continually growing. Some promising and useful tissue markers are GSTP1, HOXD3, cell cycle proteins, chromatin remodeling proteins, androgen receptor, Stat5a/b, ERG, and PTEN. Serum and urine markers are mostly either prostate-specific antigen or newer tests using one or more other kallikreins or sarcosine. The data and evidence for all of these markers and the commercial tests using them are reviewed here.

CITED BY
  1. Liu Duo, Zhu Jingjing, Zhou Dan, Nikas Emily G., Mitanis Nikos T., Sun Yanfa, Wu Chong, Mancuso Nicholas, Cox Nancy J., Wang Liang, Freedland Stephen J., Haiman Christopher A., Gamazon Eric R., Nikas Jason B., Wu Lang, A transcriptome‐wide association study identifies novel candidate susceptibility genes for prostate cancer risk, International Journal of Cancer, 150, 1, 2022. Crossref

  2. Garcia‐Marques Fernando, Liu Shiqin, Totten Sarah M., Bermudez Abel, Tanimoto Cheylene, Hsu En‐Chi, Nolley Rosalie, Hembree Amy, Stoyanova Tanya, Brooks James D., Pitteri Sharon J., Protein signatures to distinguish aggressive from indolent prostate cancer, The Prostate, 82, 5, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain